MAPK1 and hepatocellular carcinoma: These results are consistent with the characteristics of the genes, suggesting that TanIIA may play a therapeutic role in HCC by regulating their expression levels, and SRC/MAPK/ERK signaling pathway may be related to TanIIA in the treatment of HCC.